Medicare Part D - Veracyte Announces Medicare Coverage for Its Afirma Gene Expression Classifier
Veracyte Announces Medicare Coverage for Its Afirma Gene Expression Classifier for Improved Thyroid Nodule Diagnosis
SOUTH SAN FRANCISCO, Calif. , Jan. 9, 2012 /PRNewswire/ -- Veracyte, Inc ., a molecular diagnostics company pioneering the emerging field of molecular cytology, today announced that Palmetto GBA, ...
Gingrich urged yes vote on controversial Medicare bill, former congresswoman says
Des Moines, Iowa (CNN) - Another Republican has come forward to say that Newt Gingrich personally pressed her and other members of Congress in 2003 to vote for a controversial Medicare prescription drug benefit. The provision, known as Medicare Part D, passed the House that summer by a narrow margin and eventually took effect in [...]
Health Net Sells Medicare Drug Plan for $160 Million
Health Net Inc. plans to sell its Medicare Part D prescription drug plan business to a subsidiary of retail drug store operator CVS Caremark Corp. for $160 million.